Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q57417202)
Watch
English
Osteoporosis
scientific article published in The Lancet
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
16782492
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16782492%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Osteoporosis
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16782492
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16782492%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
main subject
osteoporosis
0 references
author
Cyrus Cooper
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
16782492
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16782492%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
author name string
Philip Sambrook
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16782492
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16782492%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
language of work or name
English
0 references
publication date
1 June 2006
1 reference
stated in
Europe PubMed Central
PubMed ID
16782492
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16782492%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed ID
16782492
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16782492%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
volume
367
1 reference
stated in
Europe PubMed Central
PubMed ID
16782492
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16782492%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
page(s)
2010-2018
1 reference
stated in
Europe PubMed Central
PubMed ID
16782492
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16782492%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
issue
9527
1 reference
stated in
Europe PubMed Central
PubMed ID
16782492
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16782492%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
cites work
Epidemiology and outcomes of osteoporotic fractures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidemiology of fractures in England and Wales
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A meta-analysis of previous fracture and subsequent fracture risk
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The socioeconomic burden of fractures: today and in the 21st century
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pre-existing fractures and bone mass predict vertebral fracture incidence in women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vertebral fractures predict subsequent fractures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mortality after all major types of osteoporotic fracture in men and women: an observational study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prenatal and childhood influences on osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gender Differences in the Genetic Factors Responsible for Variation in Bone Density and Ultrasound
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gain in bone mineral mass in prepubertal girls 3.5 years after discontinuation of calcium supplementation: a follow-up study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vitamin D receptor gene polymorphisms and the risk of fractures in older women. For the Study of Osteoporotic Fractures Research Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Association of collagen Ialpha 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Osteoclast differentiation and activation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High bone density due to a mutation in LDL-receptor-related protein 5
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of LRP5 Polymorphisms on Normal Variation in BMD
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessment of fracture risk
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biochemical indices of bone turnover and the assessment of fracture probability
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of falls and consequent injuries in elderly people
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hip protectors for preventing hip fractures in older people
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vitamin D3 and calcium to prevent hip fractures in elderly women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Calcium plus vitamin D supplementation and the risk of fractures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Uncertain future of trials in osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ten years' experience with alendronate for osteoporosis in postmenopausal women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The impact of compliance with osteoporosis therapy on fracture rates in actual practice.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early discontinuation of treatment for osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous zoledronic acid in postmenopausal women with low bone mineral density
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
What PROOF proves about calcitonin and clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Daily and cyclic parathyroid hormone in women receiving alendronate.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Denosumab in postmenopausal women with low bone mineral density
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968891-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(06)68891-0
1 reference
stated in
Europe PubMed Central
PubMed ID
16782492
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16782492%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
PubMed ID
16782492
1 reference
stated in
Europe PubMed Central
PubMed ID
16782492
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16782492%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit